Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Globus Medical (GMED)

Globus Medical names Keith Pfeil CEO after Daniel Scavilla resigns

Mixed Impact 4 of 5 leadership Written later

Daniel Scavilla resigned as Globus Medical's President, CEO and director effective July 18, 2025, to pursue another opportunity. The board named Keith Pfeil, the company's COO and CFO, as President and CEO and a director, and Kyle Kline as CFO, effective the same day. The company also reported preliminary second-quarter 2025 sales of approximately $745.3 million, up 18.4% as reported, and reaffirmed its full-year 2025 guidance.

Key points

  • Daniel Scavilla resigned as President, CEO and director effective July 18, 2025; the filing says the resignation was not due to any disagreement with the company.
  • Keith Pfeil was appointed President and CEO effective July 18, 2025, with his base salary rising to $490,000, prorated for 2025.
  • Preliminary Q2 2025 sales were approximately $745.3 million, up 18.4% as reported; base business sales were approximately $650.8 million, up 3.3%.
  • The company reaffirmed full-year 2025 revenue guidance of $2.80 billion to $2.90 billion and non-GAAP diluted EPS guidance of $3.00 to $3.30.

The filing

CompanyGlobus Medical (GMED)
Form8-K, current report
Filed with the SECJul 21, 2025, 8:05 AM ET
Accession number0001562762-25-000166

Items reported: 2.02 Results of Operations5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 21, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.